05:28 PM EDT, 08/05/2024 (MT Newswires) -- Encompass Health ( EHC ) reported Q2 adjusted earnings late Monday of $1.11 per diluted share, up from $0.95 per share a year earlier.

Analysts polled by Capital IQ expected $1.01.

Net operating revenue for the quarter ended June 30 increased to $1.30 billion from $1.19 billion a year earlier.

Analysts surveyed by Capital IQ expected $1.30 billion.

For 2024, the company now expects adjusted EPS of $3.97 to $4.22 on revenue of $5.28 billion to $5.35 billion, up from its prior ranges of $3.86 to $4.11 and $5.25 billion to $5.33 billion.

The consensus is for $4.11 and $5.31 billion, respectively.